[Diagnosis and treatment of basal cell carcinoma : A question of the risk of recurrence]. / Diagnostik und Therapie des Basalzellkarzinoms : Eine Frage des Rezidivrisikos.
Hautarzt
; 71(8): 580-587, 2020 Aug.
Article
em De
| MEDLINE
| ID: mdl-32533202
ABSTRACT
Basal cell carcinoma is the most common type of cancer in Central Europe and has a high medical relevance. Due to its high tendency of recurrence, an important parameter in the planning of therapy is the risk of recurrence. After clinical and histological diagnosis, the majority of tumors are treated surgically, although radiation and topical procedures are also possible therapeutic alternatives in certain constellations. Hedgehog inhibitors, a completely new class of substances, have recently been approved for rare metastatic and locally advanced diseases, thus significantly expanding the range of treatments. This article provides an overview of the current guideline-based diagnosis and therapy of basal cell carcinomas in Germany.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Carcinoma Basocelular
/
Guias de Prática Clínica como Assunto
/
Procedimentos Cirúrgicos Dermatológicos
/
Antineoplásicos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
De
Ano de publicação:
2020
Tipo de documento:
Article